PDTC (NF-κB抑制剂/抗氧化剂)
收藏
产品编号 S1809
数量
¥ 366.00
产品包装:
1g 5g
产品简介
使用说明
相关文件下载
相关产品
相关论文
产品问答

PDTC的全称为Ammonium pyrrolidinedithiocarbamate或Pyrrolidinedithiocarbamic acid,ammonium salt,是一种可
以通透细胞膜的NF-κB活化(NF-κB activation)抑制剂,可以在多种细胞中抑制NF-κB的激活。PDTC也是一种抗氧化剂(antioxidant),也是一种金属离子螯合剂(metal chelator),并且可以在酸性溶液中沉淀As,Bi,Cd,Co,Cu,Fe,Mn,Ni,Pb,Sb,Sn,V,Zn等重金属。PDTC可以诱导大鼠平滑肌细胞发生凋亡,也可以抑制白血病细胞HL-60发生凋亡。
PDTC分子量为164.29,分子式为C5H9NS2·NH3,CAS Number:5108-96-3。本产品为进口分装,纯度大于99%。
PDTC可溶于水(1mg/ml),在DMSO中的溶解度可达到100mM。
包装清单:

产品编号 产品名称 包装
S1809 PDTC(NF-κB抑制剂/抗氧化剂) 5g
说明书 1份

保存条件:
4℃保存。配制成母液后-20℃可保存3个月。
注意事项:
本产品对人体有刺激性,操作时请小心,并注意适当防护以避免直接接触人体或吸入体内。
本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
为了您的安全和健康,请穿实验服并戴一次性手套操作。

使用说明:
1. PDTC常见使用浓度范围为10-100μM。具体的最佳工作浓度请参考相关文献,或根据实验目的,以及所培养的特定细胞和组织,通过实验进行摸索和优化。
相关产品请点击如下按钮:
使用本产品的文献:
1. Li J, Liu H, Xing B, Yu Y, Wang H, Chen G, Gu B, Zhang G, Wei D, Gu P, Li M, Hu W.
NEURO-ONCOLOGY 2012 Jul;108(3):385-93. (IF 10.247)
2. Tang S, Xiang T, Huang S, Zhou J, Wang Z, Xie R, Long H, Zhu B.
Cancer Lett 2016 Jun 28;376(1):137-47. (IF 7.36)
3. Wang G, Zhu L, Yu B, Chen K, Liu B, Liu J, Qin G, Liu C, Liu H, Chen K.
CARBOHYD POLYM 2016 Sep 20;149:112-20. (IF 7.182)
4. Chen X, Jiang C, Qin B, Liu G, Ji J, Sun X, Xu M, Ding S, Zhu M, Huang G, Yan B, Zhao C.
Cell Death Dis 2017 Sep 7;8(9):e3046. (IF 6.304)
6. Bai T, Yang Y, Yao YL, Sun P, Lian LH, Wu YL, Nan JX.
Pharmacol Res 2016 Mar;105:1-12. (IF 5.893)
7. Zhao Y, Zhang C, Huang Y, Yu Y, Li R, Li M, Liu N, Liu P, Qiao J.
J CLIN ENDOCR METAB 2015 Jan;100(1):201-11. (IF 5.399)
8. Hu Y, Zang J, Cao H, Wu Y, Yan D, Qin X, Zhou L, Fan F, Ni J, Xu X, Sha H, Liu S, Yu S, Wang Z, Ma R, Wu J, Feng J.
ONCOTARGET 2017 Feb 28;8(9):15802-15814. (IF 5.168)
9. Deng C, Fu H, Shang J, Chen J, Xu X.
Int J Biol Macromol 2018 Apr 1;109:369-374. (IF 5.162)
10. Ruiyi Fan, Congyi Zhu, Diyang Qiu, Genlin Mao, Jiwu Zeng
Int J Biol Macromol. doi: 10.1016/j.ijbiomac.2019.11.172. (IF 5.162)
11. Feng C, Zhang Y, Yang M, Lan M, Liu H, Huang B, Zhou Y.
Oxid Med Cell Longev 2017;2017:7426458. (IF 5.076)
12. Wan D, Wu Q, Qu W, Liu G, Wang X
Oxid Med Cell Longev 2018 Nov 25;2018:1324173. (IF 5.076)
13. Su AR, Qiu M, Li YL, Xu WT, Song SW, Wang XH, Song HY, Zheng N, Wu ZW.
Acta Pharmacol Sin 2017 Jan 23.doi: 10.1038/aps.2016.160. [Epub ahead of print] (IF 5.064)
14. Lin D, Li L, Sun Y, Wang W, Wang X, Ye Y, Chen X, Xu Y.
Immunology 2014 Sep 29. (IF 5.016)
16. DangLi R, HeKong W, JiQin L, MingHua Z, WenCheng Z.
Mol Cell Biochem 2012 Jan;359(1-2):183-91. (IF 2.795)
17. Yang HY, Zhao L, Yang Z, Zhao Q, Qiang L, Ha J, Li ZY, You QD, Guo QL.
MOL CARCINOGEN 2012 Feb;51(2):185-95. (IF 3.825)
18. Xiao LJ, Chen YY, Lin P, Zou HF, Lin F, Zhao LN, Li D, Guo L, Tang JB, Zheng XL, Yu XG.
Int J Oncol 2012 Nov;41(5):1827-36. (IF 3.899)
19. Zhang X, Ding R, Zhou Y, Zhu R, Liu W, Jin L, Yao W, Gao X.
PLoS One 2013;8(3):e60781. (IF 2.74)
21. Fan H, Yan X, Zhang Y, Zhang X, Gao Y, Xu Y, Wang F, Meng S.
PLoS One 2013 Jun 11;8(6):e65588. (IF 2.74)
23. Cao ZH, Yin WD, Zheng QY, Feng SL, Xu GL, Zhang KQ.
Cell Biochem Biophys 2013 Dec;67(3):1239-48. (IF 2.073)
24. Wei W, Yuan YH, Gao YN, Yan WF, Li CJ, Zhang DM, Chen NH.
J Asian Nat Prod Res 2014;16(8):865-75. (IF 1.345)
25. Zhou Y, Chen S, Ding R, Yao W, Gao X.
MEDIAT INFLAMM 2014;2014:691285. (IF 3.758)
26. Yao J, Hu R, Sun J, Lin B, Zhao L, Sha Y, Zhu B, You QD, Yan T, Guo QL.
MOL CARCINOGEN 2014 Feb;53(2):145-58. (IF 3.825)
27. Shan X, Li Y, Meng X, Wang P, Jiang P, Feng Q.
Food Chem Toxicol 2014 Apr;66:194-202. (IF 4.679)
29. Zhang X, Shi Y, Weng Y, Lai Q, Luo T, Zhao J, Ren G, Li W, Pan H, Ke Y, Zhang W, He Q, Wang Q, Zhou R.
PLoS One 2014 Oct 14;9(10):e108747. (IF 2.74)
30. Cheng X, Gu J, Zhang M, Yuan J, Zhao B, Jiang J, Jia X.
Int Immunopharmacol 2014 Nov;23(1):304-13. (IF 3.943)
31. Zhao W, Ma G, Chen X.
VASC PHARMACOL 2014 Dec;63(3):162-72. (IF 4.152)
32. Ding CL, Xu G, Ren H, Zhao LJ, Zhao P, Qi ZT, Wang W.
Virus Res 2015 Jan 22;196:135-9. (IF 2.934)
34. Lu X, Ma P, Shi Y, Yao M, Hou L, Zhang P, Jiang L.
Mol Cell Endocrinol 2015 Feb 5;401:1-11. (IF 3.871)
35. Song B, Bian Q, Shao CH, Li G, Liu AA, Jing W, Liu R, Zhang YJ, Zhou YQ, Hu XG, Jin G.
PLoS One 2015 Mar 27;10(3):e0120694. (IF 2.74)
36. Han X, Wang T, Zhang J, Liu X, Li Z, Wang G, Song Q, Pang D, Ouyang H, Tang X.
Biol Open 2015 Apr 2;4(5):661-5. (IF 2.029)
37. Jiang R, Wei L, Zhu M, Wu J, Wang L.
Inflammation 2015 Apr;39(2):643-50. (IF 3.212)
38. Li Y, Wu Q, Deng Y, Lv H, Qiu J, Chi G, Feng H.
Int Immunopharmacol 2015 Jun;26(2):286-94. (IF 3.943)
41. Xu J, Jiang C, Zhu W, Wang B, Yan J, Min Z, Geng M, Han Y, Ning Q, Zhang F, Sun J, Meng L, Lu S.
OSTEOARTHR CARTILAGE 2015 Sep;23(9):1575-85. (IF 4.793)
42. Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F, Lee Y, Zhang L, Lian K, Yan W, Ma X, Liu Y, Tao L.
J Mol Cell Cardiol 2015 Oct;87:138-47. (IF 4.133)
44. Hao W, Zhang X, Zhao W, Zhu H, Liu ZY, Lu J, Chen X.
ANTI-CANCER AGENT ME 2016;16(5):593-600. (IF 2.049)
46. Fu J, Shi Q, Song X, Xia X, Su C, Liu Z, Song E, Song Y.
ENVIRON TOXICOL CHEM 2016 Jan;41:241-50. (IF 3.152)
47. Li Z, Wang S, Zhao W, Sun Z, Yan H, Zhu J.
Mol Med Rep 2016 Feb;13(2):1709-16. (IF 2.1)
48. Liu L, Sun Q, Bao R, Roth M, Zhong B, Lan X, Tian J, He Q, Li D, Sun J, Yang X, Lu S.
SCI REP-UK 2016 Feb 25;6:21810. (IF 3.998)
49. Gan T, Wang Y, Zhao M, Wu J, Yang J, Peng S.
DRUG DES DEV THER 2016 Feb 16;10:711-21. (IF 3.216)
50. Zhang DM, Bao YL, Yu CL, Wang YM, Song ZB.
Immunol Res 2016 Feb;64(1):104-14. (IF 2.507)
51. Jiang R, Wei L, Zhu M, Wu J, Wang L.
Inflammation 2016 Apr;39(2):643-50. (IF 3.212)
52. Cao T, Shao S, Li B, Jin L, Lei J, Qiao H, Wang G.
SCI REP-UK 2016 May 3;6:25381. (IF 3.998)
53. Deng QF, Sun X, Liang ZF, Zhang ZQ, Yu DX, Zhong CY.
Oncol Rep 2016 May;35(5):2665-72. (IF 3.417)
55. Qian T, Wang K, Cui J, He Y, Yang Z.
Inflammation 2016 Jun;39(3):974-85. (IF 3.212)
56. Li Y, Chi G, Shen B, Tian Y, Feng H.
Inflammation 2016 Aug;39(4):1291-301. (IF 3.212)
58. Zhang L, Zhao S, Yuan L, Wu H, Jiang H, Luo G, Zhao S.
Int Immunopharmacol 2016 Sep;38:167-74. (IF 3.943)
59. Yue X, Wu M, Jiang H, Hao J, Zhao Q, Zhu Q, Saren G, Zhang Y, Zhang X.
Mol Med Rep 2016 Sep;14(3):1979-85. (IF 2.1)
60. Linghu K, Lin D, Yang H, Xu Y, Zhang Y, Tao L, Chen Y, Shen X.
Eur J Pharmacol 2016 Oct 15;789:195-201. (IF 3.263)
62. Hua W, Zhang M, Wang Y, Yu L, Zhao T, Qiu X, Wang L.
Mol Med Rep 2016 Dec;14(6):5084-5092. (IF 2.1)
63. Wang B, Cui Z, Zhong Z, Sun Y, Yang GY, Sun Q, Bian L.
MOL CARCINOGEN 2016 Dec;55(12):2268-2277. (IF 3.825)
65. Wang YX, Li YZ, Zhang ZY, Wang JQ, Cui J, Qian XL.
Biomed Res Int 2017;2017:2948467. (IF 2.276)
66. Liu H, Xiong J, He T, Xiao T, Li Y, Yu Y, Huang Y, Xu X, Huang Y, Zhang J, Zhang B,
Am J Nephrol. 2017;46(4):333-342. (IF 3.411)
67. Liu H, Xiong J, He T, Xiao T, Li Y, Yu Y, Huang Y, Xu X, Huang Y, Zhang J, Zhang B, .
Am J Nephrol. 2017;46(4):333-342. (IF 3.411)
68. Li Y, Wang X, Ren J, Lan X, Li J, Yi J, Liu L, Han Y, Zhang S, Li D, Lu S.
BMC PHARMACOL TOXICO 2017 Jan 18;18(1):5. (IF 1.771)
69. Liu S, Zhao K, Su X, Lu L, Zhao H, Zhang X, Wang Y, Wu C, Chen J, Zhou Y, Hu X, Wang Y, Lu M, Chen X, Pei R.
PLoS One 2017 Jan 5;12(1):e0169701. (IF 2.74)
70. Wu X, Liu P, Zhang H, Li Y, Salmani JM, Wang F, Yang K, Fu R, Chen Z, Chen B.
BMC Cancer 2017 Feb 21;17(1):147. (IF 3.15)
71. Feng C, Luo Y, Nian Y, Liu D, Yin X, Wu J, Di J, Zhang R, Zhang J.
Inflammation 2017 Jun;40(3):818-831. (IF 3.212)
72. Zhang LB, Man ZT, Li W, Zhang W, Wang XQ, Sun S.
Mol Immunol 2017 Jul;87:249-257. (IF 3.641)
74. Zhou WJ, Hou XX, Wang XQ, Li DJ.
Am J Reprod Immunol 2017 Aug;78(2).doi: 10.1111/aji.12644 (IF 2.739)
75. Luo X, Zhang X, Zhao T, Zeng T, Liu W, Deng M, Zhao F.
MICROB PATHOGENESIS 2017 Sep;110:176-183. (IF 2.914)
76. Yang J, Sheng S, Yang Q, Li L, Qin S, Yu S, Zhang X.
Oncol Lett 2017 Nov;14(5):5333-5339. (IF 2.311)
78. Yao PL, Zhuo S, Mei H, Chen XF, Li N, Zhu TF, Chen ST, Wang JM, Hou RX, Le YY.
CNS Neurosci Ther 2017 Nov;23(11):855-865. (IF 4.074)
79. Li J, Xia K, Xiong M, Wang X, Yan N.
Exp Ther Med 2017 Dec;14(6):5635-5640. (IF 1.785)
80. Bao L, Li J, Zha D, Zhang L, Gao P, Yao T, Wu X.
Int Immunopharmacol 2018 Jan;54:245-253. (IF 3.943)
81. Liang K, Liu Y, Eer D, Liu J, Yang F, Hu K
MED SCI MONITOR 2018 Jan 21;24:405-411. (IF 1.918)
82. Yu S, Chen Y, Chen S, Ye N, Li Y, Sun Y.
Mol Med Rep 2018 Apr;17(4):6156-6162. (IF 2.1)
85. Zhou L, Zhan ML, Tang Y, Xiao M, Li M, Li QS, Yang L, Li X, Chen WW, Wang YL
Int J Oncol 2018 Oct;53(4):1613-1624. (IF 3.899)
87. Wang Y, Liu J, Chen X, Sun H, Peng S, Kuang Y, Pi J, Zhuang T, Zhang L, Yu Z, Tomlinson B, Chan P, Chen Y, Zhang Y, Li Y
J Cell Mol Med. 23(1):476-486. (IF 4.486)
88. Li H, Hou H, Liu S, Feng Y, Zhong W, Hu X, Yan N
Turk J Med Sci 2019 Feb 11;49(1):422-428. (IF 0.717)
89. Meng R, Li D, Feng Z, Xu Q
Cell Tissue Res 2019 Jun;376(3):413-423. (IF 4.044)
90. Wu A, Liu F, Liu X, Feng X, Lin H
Eur J Obstet Gynecol Reprod Biol 2019 Jun;237:209-214.
91. Ma GG, Shi B, Zhang XP, Qiu Y, Tu GW, Luo Z
Ann Transl Med. 7(18):473. (IF 3.297)
92. An G, Wu F, Huang S, Feng L, Bai J, Gu S, Zhao X
Oncol Rep. 42(6):2499-2511. (IF 3.417)
93. Xian-Kuan Xie, Zheng-Kuan Xu, Kan Xu, Yu-Xiang Xiao
Neurol Res. doi: 10.1080/01616412.2019.1685068. (IF 2.401)
94. Chunou Tian, Zifu Li, Lei Zhang, Dongwei Dai, Qinghai Huang, Jianmin Liu, Bo Hong
Gene. doi: 10.1016/j.gene.2019.144285. (IF 2.984)
95. Hongda Ding, Xixia Zhang, Yang Su, Changjun Jia, Chaoliu Dai
Cell Mol Biol Lett. doi: 10.1186/s11658-020-00204-1. (IF 3.451)
96. Ke Yang, Lianghui Zhan, Tingting Lu, Cong Zhou, Xue Chen, Yingjie Dong, Guiyuan Lv, Suhong Chen
Cytokine. doi: 10.1016/j.cyto.2020.155058. (IF 2.952)
97. Qiu-Nan Chen, Zhen Fan, An-Kang Lyu, Jing Wu, Ai Guo, Yun-Fei Yang, Jin-Liang Chen, Qian Xiao
Exp Cell Res. doi: 10.1016/j.yexcr.2020.111890. (IF 3.383)
98. Bo Hu, Lixu Xu, Ying Li, Xu Bai, Maochen Xing, Qi Cao, Hao Liang, Shuliang Song, Aiguo Ji
J Ethnopharmacol. doi: 10.1016/j.jep.2020.112723. (IF 3.69)
99. Yuehua Shi, Jie Qian, Qinfen Zhang, Yan Hu, Dongdong Sun, Li Jiang
Eur J Obstet Gynecol Reprod Biol. doi: 10.1016/j.ejogrb.2020.04.058.
100. Lei Wang, Ying-Shuang Li, Lu-Gang Yu, Xin-Ke Zhang, Lin Zhao, Fu-Lian Gong, Xiao-Xia Yang, Xiu-Li Guo
Biochem Pharmacol. doi: 10.1016/j.bcp.2020.114113. (IF 4.96)
101. Yufan Zhang, Qinfang Wu, Limin Zhong, Lei Wang, Dongwei Gong
Mol Med Rep. doi: 10.3892/mmr.2020.11201. (IF 2.1)
102. Ni Jiao, Yuping Chen, Yihui Zhu, Wei Wang, Mengxue Liu, Wangli Ding, Gaohong Lv, Jinfu Lu, Bin Yu, Huiqin Xu
Life Sci. doi: 10.1016/j.lfs.2019.116736. (IF 3.647)
103. Xinnong Liu, Chengjia Qu, Yongbao Zhang, Jie Fang, Lequn Teng, Rujiao Zhang, Xiangyu Zhang, Chenyang Shen
FEBS Open Bio. doi: 10.1002/2211-5463.12942. (IF 2.231)
104. Jie Liu, Yan Jiang, Min Han, Liwei Jiang, Dapeng Liang, Shenling Li, Zhenju Xu, Lin Wang, Na Li
Int Immunopharmacol. doi: 10.1016/j.intimp.2020.106522. (IF 3.943)
105. Lingli Kong, Laifang Wang, Qing Zhao, Guijuan Di, Huiqiang Wu
J Biochem Mol Toxicol. doi: 10.1002/jbt.22551.
106. Yu Ou, Lei Zhu, Shuya Xu, Qingfang Wei
Fundam Clin Pharmacol. doi: 10.1111/fcp.12550.
107. Ling-Jun Kong, Ya-Nan Wang, Zi Wang, Qian-Zhou Lv
Herz. doi: 10.1007/s00059-020-04996-y. (IF 1.033)